Ayzsa Tannis

1. Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus–Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season — New Vaccine Surveillance Network, October 2023–February 2024
   2024/03/07 by Heidi L. Moline, Ayzsa Tannis, Ariana P. Toepfer +52 · 2 citations
   Medicine · #Pneumonia and Respiratory Infections #Respiratory viral infections research #Tracheal and airway disorders